UnitedHealth Group Incorporated (UNH.DE)
EUR 475.6
(4.4%)
EUR 475.6
(4.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 371.62 Billion | 322.13 Billion | 285.27 Billion | 255.63 Billion | 240.26 Billion | 224.87 Billion |
| Cost of Revenue | 280.66 Billion | 244.54 Billion | 217.94 Billion | 190.14 Billion | 184.55 Billion | 172.4 Billion |
| Gross Profit | 90.95 Billion | 77.58 Billion | 67.32 Billion | 65.49 Billion | 55.71 Billion | 52.47 Billion |
| Operating Expenses | 339.26 Billion | 51.18 Billion | 45.68 Billion | 44.59 Billion | 37.91 Billion | 36.5 Billion |
| Selling, General and Administrative Expenses | 54.62 Billion | 47.78 Billion | 42.57 Billion | 41.7 Billion | 35.19 Billion | 34.07 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 284.63 Billion | 51.18 Billion | 45.68 Billion | 44.59 Billion | 37.91 Billion | 36.5 Billion |
| Cost and Expenses | 339.26 Billion | 295.72 Billion | 263.62 Billion | 234.73 Billion | 222.47 Billion | 208.9 Billion |
| Operating Income | 32.35 Billion | 28.43 Billion | 23.97 Billion | 22.4 Billion | 19.68 Billion | 17.34 Billion |
| Interest Expense | 3.24 Billion | 2.09 Billion | 1.66 Billion | 1.66 Billion | 1.7 Billion | 1.4 Billion |
| Income Tax Expense | 5.96 Billion | 5.7 Billion | 4.57 Billion | 4.97 Billion | 3.74 Billion | 3.56 Billion |
| Earnings before Tax | 29.11 Billion | 26.34 Billion | 22.31 Billion | 20.74 Billion | 17.98 Billion | 15.94 Billion |
| Net Income | 22.38 Billion | 20.12 Billion | 17.28 Billion | 15.4 Billion | 13.83 Billion | 11.98 Billion |
| Earnings Per Share Basic | 23.86 | 21.47 | 18.33 | 16.23 | 14.55 | 12.45 |
| Earnings Per Share Diluted | 23.86 | 21.18 | 18.08 | 16.03 | 14.33 | 12.19 |
| Weighted Average Shares Outstanding | 938.01 Million | 934 Million | 943 Million | 949 Million | 951 Million | 963 Million |
| Weighted Average Shares Outstanding (Diluted) | 938 Million | 950 Million | 956 Million | 961 Million | 966 Million | 983 Million |
| Gross Margin | 0.24 | 0.24 | 0.24 | 0.26 | 0.23 | 0.23 |
| EBIT Margin | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 |
| Profit Margin | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
| EBITDA | 36.33 Billion | 31.83 Billion | 27.07 Billion | 25.29 Billion | 22.4 Billion | 19.77 Billion |
| Earnings Before Tax Margin | 0.09 | 0.09 | 0.08 | 0.09 | 0.08 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 97.85 Billion | 99.79 Billion | 371.62 Billion | 94.42 Billion | 92.36 Billion | 91.78 Billion |
| Cost of Revenue | 76.79 Billion | 76.79 Billion | 280.66 Billion | 72.42 Billion | 68.97 Billion | 70.01 Billion |
| Gross Profit | 21.06 Billion | 23 Billion | 90.95 Billion | 22 Billion | 23.38 Billion | 21.77 Billion |
| Operating Expenses | 14.18 Billion | 15.07 Billion | 58.6 Billion | 14.31 Billion | 14.86 Billion | 14.83 Billion |
| Selling, General and Administrative Expenses | 13.16 Billion | 14.07 Billion | - | 13.33 Billion | 13.85 Billion | 13.8 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 77.81 Billion | - | - | - | - | 14.83 Billion |
| Cost and Expenses | 90.98 Billion | 91.86 Billion | 339.26 Billion | 86.73 Billion | 83.83 Billion | 84.84 Billion |
| Operating Income | 7.87 Billion | 7.93 Billion | 32.35 Billion | 7.68 Billion | 8.52 Billion | 8.05 Billion |
| Interest Expense | 985 Million | 844 Million | 3.24 Billion | 830 Million | 834 Million | 828 Million |
| Income Tax Expense | 1.24 Billion | 1.22 Billion | 5.96 Billion | 1.18 Billion | 1.65 Billion | 1.57 Billion |
| Earnings before Tax | 5.66 Billion | 1 Million | 29.11 Billion | 6.85 Billion | 7.69 Billion | 7.22 Billion |
| Net Income | 4.21 Billion | -1.4 Billion | 22.38 Billion | 5.45 Billion | 5.84 Billion | 5.47 Billion |
| Earnings Per Share Basic | 4.54 | -1.53 | - | 5.90 | 6.31 | 5.88 |
| Earnings Per Share Diluted | 4.54 | -1.53 | - | 5.83 | 6.24 | 5.82 |
| Weighted Average Shares Outstanding | 928.63 Million | 922 Million | 928 Million | 924.92 Million | 926 Million | 930 Million |
| Weighted Average Shares Outstanding (Diluted) | 928 Million | 922 Million | 938 Million | 935 Million | 936 Million | 940 Million |
| Gross Margin | 0.22 | 0.23 | 0.24 | 0.23 | 0.25 | 0.24 |
| EBIT Margin | 0.08 | 0.09 | - | 0.09 | 0.10 | 0.09 |
| Profit Margin | 0.04 | -0.01 | 0.06 | 0.06 | 0.06 | 0.06 |
| EBITDA | 7.89 Billion | 8.92 Billion | - | 8.66 Billion | 9.53 Billion | 7.96 Billion |
| Earnings Before Tax Margin | 0.08 | 0.08 | 0.09 | 0.08 | 0.09 | 0.09 |
002162
CNH
300451
GULFNAV
AARTIPHARM
SELAN